Exact Mass: 407.21685840000004
Exact Mass Matches: 407.21685840000004
Found 500 metabolites which its exact mass value is equals to given mass value 407.21685840000004,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Leu-Leu-Tyr
C21H33N3O5 (407.24200880000006)
Acquisition and generation of the data is financially supported in part by CREST/JST. KEIO_ID L007
Geranylgeranylcysteine
C23H37NO3S (407.2494012000001)
Geranylgeranylcysteine is a modified thioether amino acid in which an isoprenyl group (geranylgeranyl) has been attached to the sulfhydryl group of cysteine through a thioether bond. Geranylgeranylcysteine is typically formed through posttranslational (prenylation) protein modification whereupon degradation of the parent protein leaves the modified (prenylated) amino acid. Prenylation is a relatively recently discovered post-translational modification of proteins that directs cytosollic proteins to membranes while at the same time activating them functionally. The change in hydrophobicity that is essential for membrane binding is done via the covalent attachment of a polyisoprene (such as a farnesyl or geranylgeranyl group) to a C-terminal cysteine by a thioether bond. Prenylated proteins can comprise up to 2\\% of total cellular protein. Prenylcysteine lyase is an enzyme that is capable of cleaving the thiother bond in prenylcysteines and is used to help in the turnover of prenylated proteins. Prenylcysteine lyase deficiency leads to the accumulation of farnesylcysteine and geranylgeranylcysteine in brain and liver. (PMID: 9287348) [HMDB] Geranylgeranylcysteine is a modified thioether amino acid in which an isoprenyl group (geranylgeranyl) has been attached to the sulfhydryl group of cysteine through a thioether bond. Geranylgeranylcysteine is typically formed through posttranslational (prenylation) protein modification whereupon degradation of the parent protein leaves the modified (prenylated) amino acid. Prenylation is a relatively recently discovered post-translational modification of proteins that directs cytosollic proteins to membranes while at the same time activating them functionally. The change in hydrophobicity that is essential for membrane binding is done via the covalent attachment of a polyisoprene (such as a farnesyl or geranylgeranyl group) to a C-terminal cysteine by a thioether bond. Prenylated proteins can comprise up to 2\\% of total cellular protein. Prenylcysteine lyase is an enzyme that is capable of cleaving the thiother bond in prenylcysteines and is used to help in the turnover of prenylated proteins. Prenylcysteine lyase deficiency leads to the accumulation of farnesylcysteine and geranylgeranylcysteine in brain and liver. (PMID: 9287348).
Neurotensin 11-13
C21H33N3O5 (407.24200880000006)
Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system. Neurotensin was first isolated from extracts of bovine hypothalamus based on its ability to cause a visible vasodilation in the exposed cutaneous regions of anesthetized rats. This structure shows the 11-13 fragment of neurotensin. Neurotensin is a 13 amino acid neuropeptide that is implicated in the regulation of luteinizing hormone and prolactin release and has significant interaction with the dopaminergic system. Neurotensin was first isolated from extracts of bovine hypothalamus based on its ability to cause a visible vasodilation in the exposed cutaneous regions of anesthetized rats
N-Arachidonoyl Cysteine
C23H37NO3S (407.2494012000001)
N-arachidonoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is an Arachidonic acid amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Arachidonoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Arachidonoyl Cysteine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
4-Methyl Erlotinib Hydrochloride
Ancistrocladine
C25H29NO4 (407.20964740000005)
1,3(2H,4H)-Isoquinolinedione, 2-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-4,4-dimethyl-
C24H29N3O3 (407.22088040000006)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists ARC 239 is an α2B/C-adrenergic receptor antagonist with pKi of 7.06 and 6.95 for rat kidney α2B and human α2C, respectively. ARC 239 also inhibits 5-HT1A receptor with a Ki of 63.1 nM[1][2].
Bidisomide, (+)-isomer
C22H34ClN3O2 (407.23394140000005)
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
Dibutyryl adenosine
n6,2'-o-dibutyryladenosine
PDE-4 Inhibitors
N-phenyl[(9,11,13-trimethyl-8,15-dioxatetracyclo[10.2.2.0<2,7>.0<9,14>]hexadec a-2(7),3,5-trien-12-yl)methoxy]carboxamide
C25H29NO4 (407.20964740000005)
relative retention time with respect to 9-anthracene Carboxylic Acid is 1.405 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.404
(3Z,6S)-3-{{2-(1,1-dimethylprop-2-en-1-yl)-7-[(2E)-4-hydroxy-3-methylbut-2-en-1-yl]-1H-indol-3-yl}methylidene}-6-methylpiperazine-2,5-dione|variecolorin M
C24H29N3O3 (407.22088040000006)
1-hydroxy-3,5-dimethoxy-2,4-bis-(3-methyl-but-2-enyl)-10H-acridin-9-one|atalaphylline 3,5-dimethyl ether|atalaphylline-3,5-dimethyl ether
C25H29NO4 (407.20964740000005)
1alpha,12alpha-epoxy-20-ethyl-14alpha,16beta-dimethoxy-aconitane-4,8,9-triol|Excelsin
C22H33NO6 (407.23077580000006)
(3S,6S)-3-((1,7-dihydro-7,7-dimethyl-2-(2-methylbut-3-en-2-yl)pyrano[2,3-g]indol-3-yl)methyl)-6-methylpiperazine-2,5-dione|talathermophilin D
C24H29N3O3 (407.22088040000006)
5,13-dihydroxy-2,4,6,14-tetramethyl-15-(2-methyl-1,3-thiazol-4-yl)pentadeca-10,14-dien-3-one
C23H37NO3S (407.2494012000001)
4-(1,3-Dimethyl-6,8-dimethoxy-1,2,3,4-tetrahydroisoquinoline-5-yl)-6-methyl-8-methoxynaphthalene-1-ol
C25H29NO4 (407.20964740000005)
6-O-methyl-4-O-demethylancistrocladine|6-O-methyl-4-O-demethylhamatine
C25H29NO4 (407.20964740000005)
3-(4,6-dipyrrolidin-1-yl-1,3,5-triazin-2-yl)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one, 11-(4,6-dipyrrolidinyl-1,3,5-triazin-2-yl)-7,11-diazatricyclo[7.3.1.0<2,7>]tri deca-2,4-dien-6-one
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.968 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.973
1,5-dihydroxy-3-methoxy-10-methyl-2,4-bis(3-methylbut-2-enyl)acridin-9-one
C25H29NO4 (407.20964740000005)
C22H33NO6_(5aS,9S,9aR)-9b-Hydroxy-6,6,9a-trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate
C22H33NO6 (407.23077580000006)
C22H33NO6_Valine, N-acetyl-, 1,3,5,5a,6,7,8,9,9a,9b-decahydro-9b-hydroxy-6,6,9a-trimethyl-3-oxonaphtho[1,2-c]furan-9-yl ester
C22H33NO6 (407.23077580000006)
C17H29NO10_2-{[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy}-3-methylbutanenitrile
Monticoline
C22H33NO6 (407.23077580000006)
Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid
Ala Cys Lys Ser
C15H29N5O6S (407.18384540000005)
Ala Cys Ser Lys
C15H29N5O6S (407.18384540000005)
Ala Phe Gly Asn
Ala Phe Asn Gly
Ala Gly Phe Asn
Ala Gly Asn Phe
Ala Lys Cys Ser
C15H29N5O6S (407.18384540000005)
Ala Lys Ser Cys
C15H29N5O6S (407.18384540000005)
Ala Asn Phe Gly
Ala Asn Gly Phe
Ala Ser Cys Lys
C15H29N5O6S (407.18384540000005)
Ala Ser Lys Cys
C15H29N5O6S (407.18384540000005)
Cys Ala Lys Ser
C15H29N5O6S (407.18384540000005)
Cys Ala Ser Lys
C15H29N5O6S (407.18384540000005)
Cys Gly Lys Thr
C15H29N5O6S (407.18384540000005)
Cys Gly Thr Lys
C15H29N5O6S (407.18384540000005)
Cys Lys Ala Ser
C15H29N5O6S (407.18384540000005)
Cys Lys Gly Thr
C15H29N5O6S (407.18384540000005)
Cys Lys Ser Ala
C15H29N5O6S (407.18384540000005)
Cys Lys Thr Gly
C15H29N5O6S (407.18384540000005)
Cys Ser Ala Lys
C15H29N5O6S (407.18384540000005)
Cys Ser Lys Ala
C15H29N5O6S (407.18384540000005)
Cys Thr Gly Lys
C15H29N5O6S (407.18384540000005)
Cys Thr Lys Gly
C15H29N5O6S (407.18384540000005)
Phe Ala Gly Asn
Phe Ala Asn Gly
Phe Gly Ala Asn
Phe Gly Gly Lys
C19H29N5O5 (407.21685840000004)
Phe Gly Gly Gln
Phe Gly Lys Gly
C19H29N5O5 (407.21685840000004)
Phe Gly Asn Ala
Phe Gly Gln Gly
Phe Lys Gly Gly
C19H29N5O5 (407.21685840000004)
Phe Asn Ala Gly
Phe Asn Gly Ala
Phe Gln Gly Gly
Gly Ala Phe Asn
Gly Ala Asn Phe
Gly Cys Lys Thr
C15H29N5O6S (407.18384540000005)
Gly Cys Thr Lys
C15H29N5O6S (407.18384540000005)
Gly Phe Ala Asn
Gly Phe Gly Lys
C19H29N5O5 (407.21685840000004)
Gly Phe Gly Gln
Gly Phe Lys Gly
C19H29N5O5 (407.21685840000004)
Gly Phe Asn Ala
Gly Phe Gln Gly
Gly Gly Phe Lys
C19H29N5O5 (407.21685840000004)
Gly Gly Phe Gln
Gly Gly Lys Phe
C19H29N5O5 (407.21685840000004)
Gly Gly Gln Phe
Gly Lys Cys Thr
C15H29N5O6S (407.18384540000005)
Gly Lys Phe Gly
C19H29N5O5 (407.21685840000004)
Gly Lys Gly Phe
C19H29N5O5 (407.21685840000004)
Gly Lys Thr Cys
C15H29N5O6S (407.18384540000005)
Gly Asn Ala Phe
Gly Asn Phe Ala
Gly Gln Phe Gly
Gly Gln Gly Phe
Gly Thr Cys Lys
C15H29N5O6S (407.18384540000005)
Gly Thr Lys Cys
C15H29N5O6S (407.18384540000005)
Lys Ala Cys Ser
C15H29N5O6S (407.18384540000005)
Lys Ala Ser Cys
C15H29N5O6S (407.18384540000005)
Lys Cys Ala Ser
C15H29N5O6S (407.18384540000005)
Lys Cys Gly Thr
C15H29N5O6S (407.18384540000005)
Lys Cys Ser Ala
C15H29N5O6S (407.18384540000005)
Lys Cys Thr Gly
C15H29N5O6S (407.18384540000005)
Lys Phe Gly Gly
C19H29N5O5 (407.21685840000004)
Lys Gly Cys Thr
C15H29N5O6S (407.18384540000005)
Lys Gly Phe Gly
C19H29N5O5 (407.21685840000004)
Lys Gly Gly Phe
C19H29N5O5 (407.21685840000004)
Lys Gly Thr Cys
C15H29N5O6S (407.18384540000005)
Lys Ser Ala Cys
C15H29N5O6S (407.18384540000005)
Lys Ser Cys Ala
C15H29N5O6S (407.18384540000005)
Lys Ser Ser Ser
Lys Thr Cys Gly
C15H29N5O6S (407.18384540000005)
Lys Thr Gly Cys
C15H29N5O6S (407.18384540000005)
Asn Ala Phe Gly
Asn Ala Gly Phe
Asn Phe Ala Gly
Asn Phe Gly Ala
Asn Gly Ala Phe
Asn Gly Phe Ala
Gln Phe Gly Gly
Gln Gly Phe Gly
Gln Gly Gly Phe
Ser Ala Cys Lys
C15H29N5O6S (407.18384540000005)
Ser Ala Lys Cys
C15H29N5O6S (407.18384540000005)
Ser Cys Ala Lys
C15H29N5O6S (407.18384540000005)
Ser Cys Lys Ala
C15H29N5O6S (407.18384540000005)
Ser Lys Ala Cys
C15H29N5O6S (407.18384540000005)
Ser Lys Cys Ala
C15H29N5O6S (407.18384540000005)
Ser Lys Ser Ser
Ser Ser Lys Ser
Ser Ser Ser Lys
Thr Cys Gly Lys
C15H29N5O6S (407.18384540000005)
Thr Cys Lys Gly
C15H29N5O6S (407.18384540000005)
Thr Gly Cys Lys
C15H29N5O6S (407.18384540000005)
Thr Gly Lys Cys
C15H29N5O6S (407.18384540000005)
Thr Lys Cys Gly
C15H29N5O6S (407.18384540000005)
Thr Lys Gly Cys
C15H29N5O6S (407.18384540000005)
Geranylgeranylcysteine
C23H37NO3S (407.2494012000001)
9b-Hydroxy-6,6,9a-trimethyl-3-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-9-yl N-acetylvalinate
C22H33NO6 (407.23077580000006)
MK-2206
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C155764 - AKT Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
N-[[5-(dimethylamino)-1-naphthyl]sulphonyl]-L-alanine, compound with piperidine (1:1)
C20H29N3O4S (407.1878674000001)
R-(N-BENZYL-2-AMINO)-1-(4-METHOXYPHENYL)PROPANE (S)-MANDELIC ACID SALT
C25H29NO4 (407.20964740000005)
(2S,3R)-BENZYL 3-METHYL-2-(METHYLAMINO)PENTANOATE 4-METHYLBENZENESULFONATE
C21H29NO5S (407.17663440000007)
Methanone, [4-(3,5-dimethoxyphenyl)-1-piperazinyl](5-methyl-3-phenyl-4-isoxazolyl)-
METHYL 3-(METHYLAMINO)-4-NITROBENZENECARBOXYLATE
C25H29NO4 (407.20964740000005)
Crystal Violet Nonahydrate [Ion association reagent for spectrophotometric analysis]
C25H30ClN3 (407.21281300000004)
(S)-2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)(Methyl)Amino)-3-Cyclohexylpropanoic Acid
C25H29NO4 (407.20964740000005)
2-(4,6-Dimethylpyrimidin-2-yl)-5-((2-fluoro-6-(2H-1,2,3-triazol-2-yl)phenyl)carbonyl)octahydropyrrolo(3,4-C)pyrrole
C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent
Ciforadenant
C308 - Immunotherapeutic Agent > C2139 - Immunostimulant Ciforadenant (CPI-444) is a potent, orally active and selective adenosine A2A receptor (A2AR) antagonist, which induces antitumor responses[1].
(1S)-1,2,3,4-Tetrahydro-8-methoxy-1alpha,3beta-dimethyl-5-[(aR)-4,5-dimethoxy-2-methyl-1-naphthalenyl]isoquinoline-6-ol
C25H29NO4 (407.20964740000005)
Cyclohexyl 2-cyano-2-[3-(4-ethylpiperazin-1-yl)quinoxalin-2-yl]acetate
L-Phenylalanyl-L-asparaginyl-L-lysine
C19H29N5O5 (407.21685840000004)
7-Amino-2-Tert-Butyl-4-(4-Pyrimidin-2-Ylpiperazin-1-Yl)pyrido[2,3-D]pyrimidine-6-Carboxamide
(3Asr,4RS,8asr,8brs)-4-(2-(4-fluorobenzyl)-1,3-dioxodeacahydropyrrolo[3,4-A] pyrrolizin-4-YL)benzamidine
C23H24FN4O2+ (407.18831959999994)
BIDISOMIDE
C22H34ClN3O2 (407.23394140000005)
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents
(9b-Hydroxy-6,6,9a-trimethyl-3-oxo-1,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-9-yl) 2-acetamido-3-methylbutanoate
C22H33NO6 (407.23077580000006)
3-[4,6-di(pyrrolidin-1-yl)-1,3,5-triazin-2-yl]-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido[1,2-a][1,5]diazocin-8-one
[(2S,3S)-2-[(1S)-1-hydroxy-2-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-2-oxoethyl]-5-oxooxolan-3-yl]azanium
(2S,4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidin-1-ium-2-carboxamide
C18H35N2O6S+ (407.22157100000004)
2-[(2E)-3,7-dimethylocta-2,6-dienyl]-3,5-dihydroxy-6-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]phenolate
C25H27O5- (407.18583920000003)
(2S)-2-[[(2S)-2-[[(2S)-2-acetamido-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoyl]amino]-4-methylpentanoic acid
C16H30N3O7P (407.18212800000003)
5-[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]-5-hydroxynonane-4,6-dione
Talathermophilin D
C24H29N3O3 (407.22088040000006)
A natural product found in Talaromyces thermophilus.
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
[2-(1-Piperidinyl)-1,3-benzothiazol-6-yl]-[4-(2-pyridinyl)-1-piperazinyl]methanone
2-[5-[4-(dimethylamino)phenyl]-2-tetrazolyl]-N-[2-(4-morpholinyl)phenyl]acetamide
N-butyl-3-[1-[(2,5-dimethylphenyl)methyl]-2,4-dioxo-3-quinazolinyl]propanamide
C24H29N3O3 (407.22088040000006)
ethyl 4-(2,5-dimethylphenyl)-6-[[(4-methylphenyl)methylamino]methyl]-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylate
C24H29N3O3 (407.22088040000006)
[5-[(2-Methoxyphenoxy)methyl]-3-isoxazolyl]-(4-methyl-3-phenyl-1-piperazinyl)methanone
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8R,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8S,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8S,9R)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
Glu-Ile-Phe
C20H29N3O6 (407.20562540000003)
A tripeptide composed of L-glutamic acid, L-isoleucine and L-phenylalanine joined in sequence by peptide linkages.
N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
5-phenyl-3-[[(1R,5S)-7-(4-phenylphenyl)-3,6-diazabicyclo[3.1.1]heptan-6-yl]methyl]isoxazole
2-methoxy-N-[(4R,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
(3S,6aR,8R,10aR)-3-hydroxy-N-(3-methoxyphenyl)-8-[2-(methylamino)-2-oxoethyl]-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocine-1-carboxamide
C20H29N3O6 (407.20562540000003)
3-fluoro-N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide
3-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-pyrrolidin-1-ylethylamino)ethyl]oxan-3-yl]benzamide
3-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide
(2R,3S)-2-[(dimethylamino)methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(2-phenylethynyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C24H29N3O3 (407.22088040000006)
3-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(2-pyrrolidin-1-ylethylamino)ethyl]oxan-3-yl]benzamide
3-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide
2-methoxy-N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(5S,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
3-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide
2-[(2R,5R,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(2R,5S,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(2S,5R,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
[(1S)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C20H29N3O4S (407.1878674000001)
[(2S,3S)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-pyridin-4-ylmethanone
C24H29N3O3 (407.22088040000006)
N-[[(8S,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylcyclopropanecarboxamide
C20H33N5O4 (407.25324180000007)
2-methoxy-N-[(4S,7R,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(4S,7S,8R)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(4S,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(4S,7S,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(4R,7R,8S)-8-methoxy-4,5,7,10-tetramethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(5S,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
2-methoxy-N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide
C21H33N3O5 (407.24200880000006)
3-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide
3-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-[2-(1-pyrrolidinyl)ethylamino]ethyl]-3-oxanyl]benzamide
2-[(2S,5R,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(2R,5S,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(2S,5S,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(2S,5S,6S)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
2-[(2R,5R,6R)-5-[[(cyclopentylamino)-oxomethyl]amino]-6-(hydroxymethyl)-2-oxanyl]-N-[(4-fluorophenyl)methyl]acetamide
(2R,3R,3aS,9bS)-N-cyclobutyl-3-(hydroxymethyl)-6-oxo-1-(2-phenylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O3 (407.22088040000006)
(2S,3S,3aR,9bR)-N-cyclobutyl-3-(hydroxymethyl)-6-oxo-1-(2-phenylethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C24H29N3O3 (407.22088040000006)
[(1R)-1-ethylsulfonyl-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C20H29N3O4S (407.1878674000001)
[(1S)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O3 (407.22088040000006)
[(1R)-7-methoxy-2-[(3-methoxyphenyl)methyl]-1-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C24H29N3O3 (407.22088040000006)
[(2S,3R)-2-(hydroxymethyl)-1-(4-oxanylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-6-yl]-pyridin-4-ylmethanone
C24H29N3O3 (407.22088040000006)
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-(4-methylphenyl)phenyl]-2-oxo-N-propan-2-yl-1,4-diazabicyclo[4.2.0]octane-4-carboxamide
C24H29N3O3 (407.22088040000006)
N-ethyl-N-[[(2S,3R,4S)-4-(hydroxymethyl)-3-[4-[(E)-prop-1-enyl]phenyl]-1-propylazetidin-2-yl]methyl]pyridine-2-carboxamide
C25H33N3O2 (407.25726380000003)
2-Amino-5-[[1-[(1-carboxy-2-phenylethyl)amino]-3-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
C20H29N3O6 (407.20562540000003)
(S)-benproperine trihydrogen phosphate
C21H30NO5P (407.18615000000005)
(R)-benproperine trihydrogen phosphate
C21H30NO5P (407.18615000000005)
4-{[6-Endo-amino-6-exo-benzoyl-5-exo-phenylnorbornan-2-yl]oxy}-4-oxobutanoic acid
4-(3-Chlorophenyl)-1-(2-hydroxy-3,3-diphenylpropyl)piperazin-1-ium(1+)
9-(1,3-Benzodioxol-5-yl)-6,7-dimethoxy-3,3-dimethyl-2,4,9,9a-tetrahydroacridin-1-one
(2S)-2-[4-(4-tert-butylphenyl)sulfonylpiperazin-1-yl]-1-pyrrolidin-1-ylpropan-1-one
C21H33N3O3S (407.22425080000005)
1,3(2H,4H)-Isoquinolinedione, 2-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-4,4-dimethyl-
C24H29N3O3 (407.22088040000006)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists ARC 239 is an α2B/C-adrenergic receptor antagonist with pKi of 7.06 and 6.95 for rat kidney α2B and human α2C, respectively. ARC 239 also inhibits 5-HT1A receptor with a Ki of 63.1 nM[1][2].
(1r,4e,6s,7s,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(1's,2s,2'r,3's,6's,11'r)-6'-hydroxy-11'-[(1r)-1-hydroxypropyl]-3-methoxy-3',4-dimethyl-10'-azaspiro[furan-2,5'-tricyclo[8.4.0.0²,⁶]tetradecane]-4',5-dione
C22H33NO6 (407.23077580000006)
(3s,6s)-3-{[7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1h-chromeno[5,6-b]pyrrol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol
C24H29N3O3 (407.22088040000006)
(1r,2r,3r,4s,5s,7s,8r,9s)-4-[3-(2h-1,3-benzodioxol-5-yl)propyl]-n-(2-methylpropyl)tetracyclo[5.4.0.0²,⁵.0³,⁹]undec-10-ene-8-carboximidic acid
4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(1s,2r,3r,4r,5s,6s,8s,9s,10r,13r,16s,17s)-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-4,8,12-triol
C22H33NO6 (407.23077580000006)
(1r,3s)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(1s,3s)-5-(4,5-dimethoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
C25H29NO4 (407.20964740000005)
5-hydroxy-3-{[7-(4-hydroxy-3-methylbut-2-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6-methyl-1,6-dihydropyrazin-2-one
C24H29N3O3 (407.22088040000006)
(1r,4z,6s,7s,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(1r,3r)-5-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-6-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol
C25H29NO4 (407.20964740000005)
3-{[1-carboxy-2-(3h-imidazol-4-yl)ethyl]amino}-2-{[1-hydroxy-3-(3h-imidazol-4-yl)-2-(methylamino)propylidene]amino}butanoic acid
ancistrobertsonine D
C25H29NO4 (407.20964740000005)
{"Ingredient_id": "HBIN015986","Ingredient_name": "ancistrobertsonine D","Alias": "NA","Ingredient_formula": "C25H29NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(N1)C)OC)C3=C4C=CC=C(C4=C(C=C3C)OC)OC)O","Ingredient_weight": "407.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "35976","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10476498","DrugBank_id": "NA"}
ancistrobrevine b
C25H29NO4 (407.20964740000005)
{"Ingredient_id": "HBIN015988","Ingredient_name": "ancistrobrevine b","Alias": "NA","Ingredient_formula": "C25H29NO4","Ingredient_Smile": "CC1CC2=C(C(=CC(=C2C(N1)C)OC)O)C3=C4C=C(C=C(C4=C(C=C3)OC)OC)C","Ingredient_weight": "407.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "19529;21541","PubChem_id": "11015040","DrugBank_id": "NA"}
ancistrotanzanine c
C25H29NO4 (407.20964740000005)
{"Ingredient_id": "HBIN015998","Ingredient_name": "ancistrotanzanine c","Alias": "NA","Ingredient_formula": "C25H29NO4","Ingredient_Smile": "CC1CC2=CC(=C(C(=C2C(N1C)C)OC)C3=C(C4=C(C=CC=C4OC)C=C3C)O)O","Ingredient_weight": "407.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1147","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11350305","DrugBank_id": "NA"}
n-[(2s)-1-{[(4s,5as,9s,9as)-4-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-9-yl]oxy}-3-methyl-1-oxobutan-2-yl]ethanimidic acid
C22H33NO6 (407.23077580000006)
(1r,10s,11r,12s,22r)-16,17-dimethoxy-9-oxa-4,13-diazahexacyclo[9.8.3.2¹⁰,¹³.0¹,¹².0⁶,²².0¹⁴,¹⁹]tetracosa-6,14(19),15,17-tetraene-4-carbonitrile
C24H29N3O3 (407.22088040000006)
4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
n-[3-(n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido)propyl]benzenecarboximidic acid
C24H29N3O3 (407.22088040000006)
(3z,6s)-3-({5-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methylidene)-6-methyl-6h-pyrazine-2,5-diol
C24H29N3O3 (407.22088040000006)
3-{[7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1h-chromeno[5,6-b]pyrrol-3-yl]methyl}-6-methyl-3,6-dihydropyrazine-2,5-diol
C24H29N3O3 (407.22088040000006)
(1s,4z,6s,7s)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-8,9-diol
C22H33NO6 (407.23077580000006)
(1s,3r)-7-(5-hydroxy-4-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(1r,3s)-5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(1r,3r)-5-(5-hydroxy-4-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(3s,6r)-2-hydroxy-3-[(6-hydroxy-1h-indol-3-yl)methyl]-6-(3-methylbut-2-en-1-yl)-4,6,7,8-tetrahydro-3h-1,4-benzodiazepine-5,9-dione
(1s,3r)-5-(5-hydroxy-4-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(1r,4e,6s,7r,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
16,17-dimethoxy-9-oxa-4,13-diazahexacyclo[9.8.3.2¹⁰,¹³.0¹,¹².0⁶,²².0¹⁴,¹⁹]tetracosa-6,14(19),15,17-tetraene-4-carbonitrile
C24H29N3O3 (407.22088040000006)
7-benzyl-6-hydroxy-10-methoxy-4-(sec-butyl)-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
(1r,3s)-7-(1-hydroxy-8-methoxy-3-methylnaphthalen-2-yl)-8-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-6-ol
C25H29NO4 (407.20964740000005)
3-({5-[(3,3-dimethyloxiran-2-yl)methyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methylidene)-5-hydroxy-6-methyl-1,6-dihydropyrazin-2-one
C24H29N3O3 (407.22088040000006)
(3z,6s)-3-({7-[(2e)-4-hydroxy-3-methylbut-2-en-1-yl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methylidene)-6-methyl-6h-pyrazine-2,5-diol
C24H29N3O3 (407.22088040000006)
4-benzyl-9,9-dimethyl-6,15,17-trioxa-3-azapentacyclo[11.5.1.0¹,¹⁰.0²,⁷.0¹⁶,¹⁹]nonadeca-2,12-diene-5,18-dione
(2s)-4-amino-n-(5-amino-4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl)-2-hydroxybutanimidic acid
n-{4-[(2e)-n-[3-(dimethylamino)propyl]-3-phenylprop-2-enamido]butyl}benzenecarboximidic acid
C25H33N3O2 (407.25726380000003)
19-ethyl-7,9-dimethoxy-13-oxa-19-azaheptacyclo[9.9.0.0¹,¹⁴.0²,¹⁷.0⁴,²⁰.0⁵,¹⁰.0⁸,¹²]icosane-5,10,17-triol
C22H33NO6 (407.23077580000006)
5,10-dihydroxy-12-[(2r)-2-hydroxy-3-methylbut-3-en-1-yl]-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one
n-[(2s)-1-{[(5as,9s,9ar,9bs)-9b-hydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-9-yl]oxy}-3-methyl-1-oxobutan-2-yl]ethanimidic acid
C22H33NO6 (407.23077580000006)
2-hydroxy-3-[(6-hydroxy-1h-indol-3-yl)methyl]-6-(3-methylbut-2-en-1-yl)-4,6,7,8-tetrahydro-3h-1,4-benzodiazepine-5,9-dione
(1r,4s,7s,10s,19s)-4-benzyl-9,9-dimethyl-6,15,17-trioxa-3-azapentacyclo[11.5.1.0¹,¹⁰.0²,⁷.0¹⁶,¹⁹]nonadeca-2,12-diene-5,18-dione
1,5-dihydroxy-3-methoxy-10-methyl-2,4-bis(3-methylbut-2-en-1-yl)acridin-9-one
C25H29NO4 (407.20964740000005)
n-[1-({9-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-4-yl}oxy)-3-methyl-1-oxobutan-2-yl]ethanimidic acid
C22H33NO6 (407.23077580000006)
(1s,3r)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-6-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-8-ol
C25H29NO4 (407.20964740000005)
n-[1-({9b-hydroxy-6,6,9a-trimethyl-3-oxo-1h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-9-yl}oxy)-3-methyl-1-oxobutan-2-yl]ethanimidic acid
C22H33NO6 (407.23077580000006)
(1s,3s)-7-(5-hydroxy-4-methoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-6-ol
C25H29NO4 (407.20964740000005)
4-[(1r,3s)-6,8-dimethoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-7-yl]-8-methoxy-3-methylnaphthalen-1-ol
C25H29NO4 (407.20964740000005)
5-hydroxy-6-methyl-3-{[5-(3-methyl-2-oxobutyl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one
C24H29N3O3 (407.22088040000006)
(1r,3r)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
C25H29NO4 (407.20964740000005)
n-(4-{n-[3-(dimethylamino)propyl]-3-phenylprop-2-enamido}butyl)benzenecarboximidic acid
C25H33N3O2 (407.25726380000003)
(1r,4z,6r,7r,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(20s)-5,6,10,11-tetramethoxy-20-methyl-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C25H29NO4 (407.20964740000005)
(1r,3s)-5-(4,5-dimethoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(1s,2r,3r,4s,5r,6s,8r,9s,10s,13r,16s,17r,18s)-4,6,16,18-tetramethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-ene-8,9-diol
C22H33NO6 (407.23077580000006)
5-(4,5-dimethoxy-7-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
C25H29NO4 (407.20964740000005)
1-(3-{[(2z,5s)-3,6-dihydroxy-5-methyl-5h-pyrazin-2-ylidene]methyl}-2-(2-methylbut-3-en-2-yl)-1h-indol-5-yl)-3-methylbutan-2-one
C24H29N3O3 (407.22088040000006)
n-[1-({4-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-9-yl}oxy)-3-methyl-1-oxobutan-2-yl]ethanimidic acid
C22H33NO6 (407.23077580000006)
(1r,4z,6r,7s,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
3-({1-[(4-carbamimidamidobutyl)-c-hydroxycarbonimidoyl]-2-(4-hydroxyphenyl)ethyl}-c-hydroxycarbonimidoyl)oxirane-2-carboxylic acid
4-[(1s,3s)-6,8-dimethoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-5-yl]-8-methoxy-6-methylnaphthalen-1-ol
C25H29NO4 (407.20964740000005)
n-[(2s)-1-{[(4r,5as,9s,9as)-4-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-9-yl]oxy}-3-methyl-1-oxobutan-2-yl]ethanimidic acid
C22H33NO6 (407.23077580000006)
(1r,3s)-5-(5-hydroxy-4-methoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(1r,3r)-7-(4-hydroxy-5-methoxy-7-methylnaphthalen-1-yl)-6-methoxy-1,2,3-trimethyl-3,4-dihydro-1h-isoquinolin-8-ol
C25H29NO4 (407.20964740000005)
2-methyl-2-[3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]butanenitrile
(1r,4e,6r,7s,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(1r,2s,4s,5s,7s,8s,9s,10s,11r,12r,14s,17s,20r)-19-ethyl-7,9-dimethoxy-13-oxa-19-azaheptacyclo[9.9.0.0¹,¹⁴.0²,¹⁷.0⁴,²⁰.0⁵,¹⁰.0⁸,¹²]icosane-5,10,17-triol
C22H33NO6 (407.23077580000006)
(1r,4e,6s,7r)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(3z)-3-({5-[(3,3-dimethyloxiran-2-yl)methyl]-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl}methylidene)-6-methyl-6h-pyrazine-2,5-diol
C24H29N3O3 (407.22088040000006)
(4r,5s,6s,10z,13s,14e)-5,13-dihydroxy-2,4,6,14-tetramethyl-15-(2-methyl-1,3-thiazol-4-yl)pentadeca-10,14-dien-3-one
C23H37NO3S (407.2494012000001)
(7s,10r)-7-benzyl-4-[(2r)-butan-2-yl]-6-hydroxy-10-methoxy-15-oxa-2,5,8-triazatricyclo[8.5.0.0³,⁸]pentadeca-1,3,5,11,13-pentaen-9-one
5-hydroxy-3-{[5-(2-hydroxy-3-methylbut-3-en-1-yl)-2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-6-methyl-1,6-dihydropyrazin-2-one
C24H29N3O3 (407.22088040000006)
n-[(2s)-1-{[(4r,5as,9s,9as)-9-hydroxy-6,6,9a-trimethyl-3-oxo-1h,4h,5h,5ah,7h,8h,9h-naphtho[1,2-c]furan-4-yl]oxy}-3-methyl-1-oxobutan-2-yl]ethanimidic acid
C22H33NO6 (407.23077580000006)
2-[2-amino-3-(3h-imidazol-4-yl)-n-methylpropanamido]-3-{[1-carboxy-2-(3h-imidazol-4-yl)ethyl]amino}butanoic acid
5,10-dihydroxy-12-(2-hydroxy-3-methylbut-3-en-1-yl)-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one
2-({2-[(3-amino-1,2-dihydroxy-4-phenylbutylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-3-methylpentanoic acid
C21H33N3O5 (407.24200880000006)
3-{[(2e)-3,7-dimethylocta-2,6-dien-1-yl]oxy}-1-hydroxy-4-methoxy-10-methylacridin-9-one
C25H29NO4 (407.20964740000005)
(2r)-2-methyl-2-[(2s,3r,4r,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]butanenitrile
(1r,4z,6s,7s)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(1s,3s)-7-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
C25H29NO4 (407.20964740000005)
(1s,4z,6s,7s,11z)-4-ethylidene-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate
(2e)-n-cyclohexyl-3-[3-(2,3-dihydroxy-3-methylbutyl)-6-hydroxy-2,4-dimethoxyphenyl]prop-2-enimidic acid
C22H33NO6 (407.23077580000006)
(1s,2s,4s,6s,10r,11r,13s,14r)-8-ethyl-13,15-dimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,10,11-triol
C22H33NO6 (407.23077580000006)
n-{3-[(2e)-n-{4-[(hydroxymethylidene)amino]butyl}-3-phenylprop-2-enamido]propyl}benzenecarboximidic acid
C24H29N3O3 (407.22088040000006)
n-cyclohexyl-3-[3-(2,3-dihydroxy-3-methylbutyl)-6-hydroxy-2,4-dimethoxyphenyl]prop-2-enimidic acid
C22H33NO6 (407.23077580000006)
(2e)-n-cyclohexyl-3-{3-[(2s)-2,3-dihydroxy-3-methylbutyl]-6-hydroxy-2,4-dimethoxyphenyl}prop-2-enimidic acid
C22H33NO6 (407.23077580000006)
5,6,10,11-tetramethoxy-20-methyl-16-azapentacyclo[12.7.0.0²,⁷.0⁸,¹³.0¹⁶,²⁰]henicosa-1(14),2(7),3,5,8(13),9,11-heptaene
C25H29NO4 (407.20964740000005)